%, mainly from the fact that the Company has repaid the loan since late year of 2016. In addition, TRIS rating announced the company rating of WHA at “A-” with “Stable” outlook in the fourth quarter in 2017
%, compared to +1.2% in 4Q20 due to decline in high margin devices sale from seasonality. Cost & Expense Cost of service for 1Q21 was Bt21,126mn, increasing 3.9%YoY and 3.4%QoQ from network OPEX following 5G/4G
closed from nationwide restriction. SIM & Device margin was marginally negative at -0.5%, down from +2.7% in 2Q21 due to decline in high margin devices sale. Cost & Expense Cost of service in 3Q21 was
. Cost & Expense In 2Q24, the cost of service was Bt24,904mn, increasing 12% YoY due to higher depreciation and fibre- related cost from consolidation of TTTBB. It stayed flat QoQ, mainly from higher
centers, and EDS. Cost & Expense In 2Q24, the cost of service was Bt24,904mn, increasing 12% YoY due to higher depreciation and fibre- related cost from consolidation of TTTBB. It stayed flat QoQ, mainly
, increasing 37% YoY from TTTBB consolidation and roaming contract with NT. It increased by 11% QoQ from sizable cloud projects. Cost & Expense In 3Q24, the cost of service was Bt24,849mn, increasing 14% YoY due
" outlook, which reflects the expectation that The Company will continue to improve its performance and be able to maintain a strong financial position. December World Medical Hospital opened the World ART
Public Offering (IPO) in the second quarter of 2017. TRIS rating announced the company rating of WHA at “A-“ with “Stable” outlook in the fourth quarter in 2017. Successful conversion of WHAPF to WHART
, net loss came from low sale volume which affected from the increasing of import volume from foreign country in May and June 2019. Business Outlook Post termination of Tolling Activities in January, 2019
39% to 0.54 (Net Operating Debt/Equity) and TRIS Ratings (a strategic part- ner of S&P Global) ascribed the Company’s rating at “A+”. They also upgraded the outlook of IVL to “Posi- tive” from “Stable